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Aging is associated with a gradual loss of muscle mass termed sarcopenia, which has significant impact on quality-
of-life. Because oxidative stress is proposed to negatively impact upon musculoskeletal aging, we investigated 
links between human aging and markers of oxidative stress, and relationships to muscle mass and strength in 
young and old nonsarcopenic and sarcopenic adults. Sixteen young and 16 old males (further subdivided into “old” 
and “old sarcopenic”) were studied. The abundance of protein carbonyl adducts within skeletal muscle sarcoplas-
mic, myofibrillar, and mitochondrial protein subfractions from musculus vastus lateralis biopsies were determined 
using Oxyblot immunoblotting techniques. In addition, concentrations of recognized cytoprotective proteins (eg, 
heat shock proteins [HSP], αβ-crystallin) were also assayed. Aging was associated with increased mitochondrial 
(but not myofibrillar or sarcoplasmic) protein carbonyl adducts, independently of (stage-I) sarcopenia. Correlation 
analyses of all subjects revealed that mitochondrial protein carbonyl abundance negatively correlated with muscle 
strength ([1-repetition maximum], p = .02, r2 = −.16), but not muscle mass (p = .13, r2 = −.08). Abundance of cyto-
protective proteins, including various HSPs (HSP 27 and 70), were unaffected by aging/sarcopenia. To conclude, 
these data reveal that mitochondrial protein carbonylation increases moderately with age, and that this increase may 
impact upon skeletal muscle function, but is not a hallmark of (stage-I) sarcopenia, per se. 
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BEyOND 50 years, skeletal muscle mass declines at 0.8%–0.98%/year in men and 0.64%–0.7%/year in 
women (1), a process termed sarcopenia (from the Greek 
“sarx” for flesh and “penia” for loss) by Irwin Rosenberg 
in 1989 (2).  Sarcopenia impacts mobility, limiting inde-
pendent living and quality-of-life, and can lead to increased 
risk of cardiovascular and metabolic disease (3). However, 
although the causes of sarcopenia are multivalent, involv-
ing for example, hormonal changes, neurodegeneration, 
inflammation, oxidative stress (4), and anabolic resistance 
(5), mechanistic explanations remain poorly defined.
Perhaps the most established theory of aging is The Free 
Radical Theory of Aging (6), where excessive reactive 
oxygen species (ROS) damage proteins, lipids, and DNA 
when not appropriately balanced by cytoprotective (ie, 
antioxidant) mechanisms (7). Proteins, for instance, can be 
modified directly or indirectly by ROS and by reaction with 
secondary products of lipid peroxidation like 4-hydroxy-
2-nonenal or malondialdehyde, generating different species 
of oxidized products (8). Accumulation of oxidized proteins 
in muscle is thought to induce cellular/tissue dysfunction, 
and oxidized products may also be resistant to proteases, 
leading to further cellular damage or dysfunction (9). 
Accumulation of carbonyl groups (aldehydes and ketones) 
on protein side chains occur as a result of oxidation and 
this is considered a robust biochemical marker of oxidative 
stress (10).
Heat shock proteins (HSPs) are important components 
of the protective machinery against a multitude of stressors 
(heat shock, oxidative stress, inflammation, etc.) (11). They 
are a family of cytoprotective proteins that recognize and 
prevent the accumulation of damaged protein by repairing/
refolding damaged ones or degrading irreversibly damaged 
proteins (12). HSPs such as HSP70, HSP27, and αβ-
crystallin are constitutively expressed, but are also induced 
by stress in skeletal and cardiac muscles (13). Moreover, 
recent data revealed that plasma HSP72 is negatively corre-
lated with muscle mass, weaker grip strength, and walking 
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speed in men and women (14). However, although changes 
in HSPs with aging have been studied in blood (15,16), 
there is scant information regarding HSP expression in 
human aging and sarcopenia, and more crucially, potential 
relationships between HSPs and oxidative modifications. 
Therefore, despite the long-proposed links between 
aging, sarcopenia, and oxidative stress in skeletal muscle, 
relationships between protein oxidation, HSPs, and sarco-
penia/muscle function (eg, strength) in old humans remain 
poorly defined. Our aim was to investigate possible differ-
ences, in young and old humans, of skeletal muscle protein 
carbonyl content and HSPs expression, and examine if these 
factors are linked to aging and/or sarcopenia, in cohorts of 
physiologically characterized humans.
Materials and Methods
ethical approval
Ethical approval was obtained from the University of 
Nottingham (D/2/2006), and the study was carried out in 
accordance with the Declaration of Helsinki. All volunteers 
were health-screened by a medical practitioner and pro-
vided written consent.
Subject characteristics and Study Design
Sixteen young and 16 old males not engaged in any 
exercise regime were recruited. One week prior to study, 
strength was assessed by 1-repetition maximum (1 RM) 
of the dominant leg on a dynamic leg extension machine 
(ISO leg extension, Leisure Lines [GB] Ltd) and body com-
position by dual-energy x-ray absorptiometry (GE Lunar 
Prodigy II, GE Healthcare). Following a general low load 
warm-up, participants began the 1 RM assessment by per-
forming the leg extension at an intensity of approximately 
50% of the estimated 1 RM. After 3-minute rest, the load 
was progressively increased in order to achieve the 1 RM 
in less than five attempts with 3-minute rest between each 
repetition. If it was not possible, the test was declared void 
and repeated 48 hours later. A subgroup of older men were 
classified as sarcopenic grade I  according to the skeletal 
muscle index: appendicular lean mass/height2, when scor-
ing >1 SD below that of the young group (17). This cre-
ated three groups: young (y), old (O), and old sarcopenic 
(OS, Table 1). Participants refrained from heavy activity 72 
hour prior to study and fasted overnight before the study 
(water ad libitum). The next day (~08:30), musculus vastus 
lateralis biopsies were taken using conchotomes (18) under 
local anesthesia (1% lidocaine). Visible connective tissue/
fat was removed before muscle was snap-frozen in liquid 
nitrogen and stored at −80°C prior to analysis.
Muscle Protein Subfraction (Myofibrillar, Sarcoplasmic, 
Mitochondrial) isolations
Muscle (~25 mg for mitochondrial and 15 mg for myofi-
brillar fractions) was separately homogenized in 10 μL·mg−1 
of ice-cold buffer pH 7.5 (50 mM Tris–HCl, 1 mM EGTA, 
1 mM EDTA, 10 mM B-glycerophosphate, 50 mM NaF; 
Sigma-Aldrich, Poole, UK) and centrifuged at 10,000g. The 
supernatant (sarcoplasmic fraction) was removed and the 
myofibrillar pellet re-suspended (10 v/w) in ice-cold mito-
chondrial extraction buffer pH 7.5 (20 mM MOPS, 110 
mM KCl, 1 mM EGTA) containing 0.25 mg·mL−1 of trypsin 
and incubated for 20 minutes on ice. Albumin was added to 
quench the reaction. Samples were spun for 5 seconds and 
the pellet washed and then homogenized in eight volumes 
of ice-cold mitochondrial extraction buffer without trypsin. 
Following this, samples were centrifuged for 5 minutes at 
600g to pellet remaining myofibrils, and the supernatant was 
centrifuged for 10 minutes at 11,000g with the resulting pellet 
representing intramyofibrillar mitochondria. Protein concen-
trations were determined on a NanoDrop spectrophotometer 
(N0-1000 V.3.8; Thermo Fisher Scientific). Fraction puri-
ties were determined by western blotting (see Western Blot 
Analysis for HSPs). Approximately, 10 μg of sarcoplasmic 
and myofibrillar protein fractions and 30 μg of mitochondrial 
protein fraction were electrophoresed and then ascertained 
using antibodies against eEF-2 (sarcoplasmic marker, 1:1,000; 
New England Biolabs, Hertfordshire, UK) and cytochrome C 
Table 1. Participant Characteristics
young (n = 16) Old (n = 8) p Old Sarcopenic (n = 8) p
Age (y) 24 ± 3 68 ± 2 71 ± 3
Weight (kg) 81 ± 10 79 ± 10 ns 70 ± 10 ns
Height (m) 1.82 ± 0.04 1.77 ± 0.03 ns 1.71 ± 0.1*,† .0001
BMI (kg/m2) 24 ± 3 25 ± 2 ns 24 ± 2 ns
1 RM (kg) 81 ± 14 43 ± 13* .0001 37 ± 11* .0001
Dominant lean leg mass (kg) 11.26 ± 1563 9.86 ± 952* .0001 8.21 ± 814*,† .0001
ASM (kg) 30 ± 4.6 26.7 ± 1.9 ns 22.4 ± 2.1* .0001
SMI (kg/m2) 9.1 ± 1.2 8.5 ± 0.4 ns 7.6 ± 0.3* .001
notes: ASM = appendicular skeletal muscle mass; BMI = body mass index; ns = nonsignificant; 1 RM = 1-repetition maximum; SMI = skeletal muscle index. 
Values are means ± SD.
*Different from young (y) subjects.
†Different from old (O) subjects.
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(mitochondrial marker, 1:1,000; Cell Signaling Technology, 
Inc., Beverly, MA). Loading was confirmed for each fraction 
using pan actin loading controls as stated below in the Western 
Blot Analysis for HSPs section and confirmed via Coomassie 
staining.  Myofibrils are insoluble under these conditions (this 
fraction is typically used for MHC electrophoresis), but it was 
necessary to ensure that this fraction was not contaminated by 
mitochondria or cytoplasm.
Western Blot analysis for HSPs
Western blots were performed similarly as previously 
described (19). Briefly, 15 μg of sarcoplasmic and myofibril-
lar protein per sample was electrophoresed on 26-lane 12% 
sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
gels (Criterion XT Bis-Tris; Bio-Rad, Hemel Hempstead, 
UK) before transfer to 0.2-μm polyvinylidene fluoride 
membranes on ice at 100 V for 45 minutes. Membranes were 
blocked in 2.5% (w/v) skimmed milk in TBST (Tris-buffered 
saline and 0.1% Tween-20; both Sigma-Aldrich, Poole, UK) 
for 1 hour, prior to incubation in primary antibodies: goat 
polyclonal anti-Hsp27 (1:2,000; Santa Cruz Biotechnology, 
Santa Cruz, CA); mouse monoclonal anti-Hsp70 (1:1,000; 
Stressgen, Florence, Italy); mouse monoclonal anti-αβ-
crystallin (1:1,000; Stressgen); and rabbit anti-pan-actin 
(1:2000; Cell Signaling Technology) overnight at 4°C. 
The next day, membranes were washed (3×) in TBST and 
incubated with horseradish peroxidase-linked secondary 
antibody for 1 hour at ambient temperature (1:2000; New 
England Biolabs). Membranes were developed using elec-
trochemiluminescence for 5 minutes (Millipore Corp., 
Billerica, MA) and bands visualized/quantified by Chemidoc 
XRS (Bio-Rad Laboratories, Inc. Hercules, CA) ensuring no 
overexposure. Pan actin was used as a “loading control.”
oxyblot procedures to Determine Protein carbonylation
The presence of protein carbonyl groups was assessed 
using the Oxyblot protein oxidation detection kit (Millipore) 
according to the manufacturer’s protocol. Briefly, the carbonyl 
groups in the protein side chains were derivatized to 2,4-dini-
trophenylhydrazone by reaction with 2,4-dinitrophenylhydra-
zine. Precisely, 10 μg of protein was used for each sample, 
and the 2,4-dinitrophenol-derivatized protein samples were 
separated by polyacrylamide gel electrophoresis as described 
previously in the Western Blot Analysis for HSPs section. 
Polyvinylidene fluoride membranes were incubated for 1 
hour in the stock primary antibody (1:150 in 1% PBS/TBST 
buffer), and after washing, for 1 hour in the stock secondary 
antibody (1:300 in % PBS/TBST buffer). Membranes were 
washed 3× in TBST and visualized as described previously in 
the Western Blot Analysis for HSPs section. The abundance 
of protein carbonylation was assessed by densitometry of 
each lane on a Chemidoc XRS system (Bio-Rad Laboratories, 
Inc.), again carefully ensuring avoidance of pixel saturation. 
Normalization for lane protein loading was performed using 
Coomassie staining.
Statistical analysis
Group differences were tested by one-way analysis of 
variance with Bonferroni post hoc testing. Correlations 
were assessed by Pearson’s product moment correlation 
coefficient. The alpha-level of significance was set at p ≤ .05 
and two-tailed data are presented, except where indicated. 
Analyses were performed using GraphPad Prism version 
5.0 (GraphPad software, La Jolla, CA). Data are mean ± 
SeM or means ± SD, as indicated.
Results
Subject characteristics
The characteristics of participants are summarized in 
Table 1. Both 1 RM strength-related performance and lean 
leg mass by dual-energy x-ray absorptiometry were greater 
in the y, compared with the O and OS groups. The O group 
had significantly greater leg muscle mass compared with 
the OS but similar strength levels.
Purity of Subcellular Fractionation
The method used for mitochondrial isolation has been 
validated previously (20). However, we have also pro-
vided confirmatory validation here (Figure 1), and as can 
be seen, the purity of our mitochondrial and sarcoplasmic 
eEF2
Cytochrome C
Figure 1. Purity of protein subfractions. Immunoblot representing the relative purity of mitochondrial (A), myofibrillar (B), and sarcoplasmic (C) preparations. 
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fractions is acceptable. As described, myofibrils (action–
myosin complexes) are insoluble in lysing buffers used for 
initial fractionation of sarcoplasmic fractions, and as can 
be seen (Figure 1), there is no mitochondrial contamination 
of the sarcoplasmic fraction. However, due to the presence 
of intramyofibrillar mitochondria, myofibrillar isolation 
may not always be free of mitochondria; nonetheless, any 
remaining mitochondrial contamination in our myofibrillar 
fractions was observed to be low versus our mitochondrial 
isolation (Figure 1).
Protein carbonyl adducts
The abundance of protein carbonyl adducts was not dif-
ferent between y, O, and OS groups for sarcoplasmic and 
myofibrillar fractions (Figure  2A and B). However, there 
was a trend toward increased formation in the mitochon-
drial fraction in the O and OS groups compared with y 
(p = .08, Figure 2C). Interestingly, when older groups were 
combined, there was significantly greater (p = .03) “age-
related” levels of protein carbonyl adducts present in the 
mitochondrial fraction in the O compared with the y group 
(Figure 3).
correlation Between Protein carbonyl adducts, Muscle 
Mass, and Strength
Protein carbonyl adducts from the myofibrillar, mito-
chondrial, or sarcoplasmic fractions were not correlated to 
muscle mass (y: p = .45; O: p = .8; OS: p = .4) or strength 
(y: p = .73; O: p = .36; OS: p = .9) when plotting each group 
individually (data not shown). However, when combining 
all subjects (32 subjects), a significant negative correla-
tion was observed between protein carbonyl adducts from 
mitochondrial fraction and muscle strength (p = .02; two-
tailed, p = .01; one-tailed, r2 = −.16; Figure 4B), but not 
significantly with muscle mass (p = .13; two-tailed, p = .06; 
one-tailed, r2 = −.08; Figure 4A). No such correlations were 
evident for the sarcoplasmic and myofibrillar fractions.
HSP27, HSP70, αβ-crystallin Protein abundance
For sarcoplasmic HSP70, HSP27, and αβ-crystallin, 
there were no group differences (Figure  5A). Similarly, 
there were no significant group differences in the myofibril-
lar protein fraction for the expression of HSP70, HSP27, 
and αβ-crystallin (Figure 5B).
Discussion
To the best of our knowledge, this is the first study to 
investigate the abundance of key surrogate markers of 
oxidative damage: protein carbonyl adducts and HSPs, in 
multiple muscle fractions (myofibrillar, mitochondrial, and 
sarcoplasmic) and in groups of young and older humans. 
Moreover, from our cohort, we were uniquely able to isolate 
a group of older individuals designated as sarcopenic grade 
I, according to established criteria (17), enabling us to study 
the effects of aging in the absence and presence of sarcope-
nia. Our results reveal aging to be associated with increased 
abundance of protein carbonyl adducts, specifically in mito-
chondrial fractions. However, this increase in mitochon-
drial protein carbonylation was independent of sarcopenia 
at stage-I (ie, protein carbonyls were indistinguishable 
between O and OS). Furthermore, despite OS adults exhib-
iting reduced muscle strength and mass compared with y, 
and lower muscle mass compared with O adults, OS indi-
viduals did not present increased mitochondrial protein car-
bonyls (vs O), or increased expression of HSP27, HSP70, 
and αβ-crystallin versus y or O. Intriguingly, we observed 
a negative correlation between the degree of mitochondrial 
protein carbonylation and muscle strength (although allied 
correlations were not significant for muscle mass), inde-
pendent of age and sarcopenia, per se.
This study provides new information relating to protein 
carbonylation in distinct muscle protein fractions and in 
relation to aging and sarcopenia. Indeed, to date, whether 
the abundance of protein carbonyls alters with aging has 
yielded incongruous findings (in immunoblots typically 
performed on the sarcoplasmic protein fraction). In our 
study, we report that neither sarcoplasmic nor myofibril-
lar abundance of protein carbonyls differed between y, O, 
and OS groups. These results are in agreement with those 
of Marzani and colleagues (21) who reported similar pro-
tein carbonyl content between healthy young and older 
adults in both human vastus lateralis and rectus abdominis. 
However, they did report increased lipid peroxidation in 
the vastus lateralis of the older group. The 2,4-dinitrophe-
nylhydrazine assay used to quantify protein carbonyls is 
considered reliable to detect total protein carbonyl formed 
from different reactions. Among those, lipid peroxida-
tion products (like hydroxyl or malondialdehyde) may 
cause protein oxidation, although because these reactions 
are related to peroxidation of polyunsaturated membrane 
lipids, they may not always de facto, induce protein dam-
age. Similarly, Mecocci and colleagues (22) and Pansarasa 
and colleagues (23) did not observe differences in protein 
carbonyl content between groups of patients undergoing 
orthopedic surgery. However, they reported a tendency for 
increased concentrations of protein carbonyls in old ver-
sus young muscle. In contrast, Gianni and colleagues (24) 
reported higher content (on average 170%) of sarcoplasmic 
protein carbonyls in vastus lateralis in old compared with 
younger men.
We next reasoned that oxidation of subcellular fractions 
(eg, mitochondria, myofibrils) or the presence or absence of 
sarcopenia could influence data gathered on a more “super-
ficial” young versus old basis. For example, the rate of per-
oxide production by mitochondria reportedly increases with 
aging and has been inversely related to longevity (25). As 
a consequence, accumulation of damaged proteins due to 
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Figure 2.  Immunochemical detection of protein carbonyls from vastus lateralis muscle of young (y), old (O), and old sarcopenic (OS) groups: (A) sarcoplasmic 
fraction, (B) myofibrillar fraction, and (C) mitochondrial fraction. Data are measured in arbitrary units, measured as the ratio between the optical density (OD) 
obtained from the whole lane of the protein and the OD of Coomassie stain. Representative samples are shown. Values are presented as means ± SeM. 
D
ow
nloaded from
 https://academ
ic.oup.com
/biom
edgerontology/article/70/2/174/592557 by guest on 05 O
ctober 2020
 SaRcoPenia anD PRoTein caRBonYlaTion 179
oxidative stress may induce oxidative damage to mitochon-
drial DNA, impairing mitochondrial biogenesis and induc-
ing apoptosis during aging (26). Indeed, recent evidence has 
further highlighted decreased mitochondrial function with 
aging. For instance, mitochondria isolated from the vastus 
lateralis muscle of older adults, exhibited lower adenosine 
triphosphate synthesis rates compared with young adults, 
indicative of decreased mitochondrial function with aging 
(27). In keeping with these findings, the authors also 
observed a reduced level of ROS production, along with 
no increase in lipid peroxidation (27). These data contrast 
the commonly held ROS theory of aging and suggest mito-
chondrial dysfunction with aging to be independent of oxi-
dative stress. Moreover, this further highlights the lack of 
consensus within the literature with regards to the contri-
bution of ROS production to aging and the need for fur-
ther investigation of this phenomenon, directly in humans. 
In this study, we observed a tendency for increased protein 
carbonyl content in mitochondrial fractions when the O 
and OS groups were grouped, compared with the younger 
group (ie, an “age” effect). Although this may be linked to 
a role for oxidative stress in the impairment of mitochon-
drial function associated with aging (28), how this occurs 
in the absence of increased mitochondrial ROS produc-
tion is unknown, though we speculate that this is due to the 
slower turnover of mitochondria with advancing age (29). 
Nevertheless, our results do imply that oxidized mitochon-
drial proteins in skeletal muscle of older adults may accu-
mulate, independently of sarcopenia, at least for stage-I. 
Finally, as we observed a rather specific effect of aging on 
mitochondrial proteins, the lack of a consensus on the oxi-
dation status of muscle proteins in aging may simply relate 
to cross-contamination of the fractions, thus highlighting 
the importance of assaying subfractions separately.
HSPs function as molecular chaperones, recognizing 
modified or mis-folded proteins, in order to ensure cor-
rect folding and protein repair under cellular stress (30). 
We show herein that HSP70, HSP27, and αβ-crystallin 
are not different between groups, that is, y, O, and OS, in 
any of the protein fractions. Because HSPs are involved 
in the protein repair system (31), the unmodified expres-
sion of HSPs in muscle from young and older subjects sup-
ports our findings that there was no greater accumulation 
of damaged proteins in sarcoplasmic or myofibrillar frac-
tions, though this in contrast to the modest age-dependent 
increases in the mitochondrial fraction. Previous investiga-
tions into age-related changes in the expression of HSPs 
in human skeletal muscle have been limited. In agreement 
with our data, yamaguchi and colleagues (33) did not locate 
any difference in the expression of HSP27, αβ-crystallin, 
and HSP70 in young versus older subjects. Conversely 
Thalacker-Mercer and colleagues (33) reported increased 
expression of HSP70 in aged versus young human mus-
cle, while in contrast, HSP27 was not expressed differ-
ently. Although the chaperone activities of HSPs have been 
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Figure 4. Correlation analysis between mitochondrial protein carbonyls and 
muscle mass (A) and strength (B). Circles indicate young (y) subjects, filled trian-
gles old (O) subjects, and empty triangles represent old sarcopenic (OS) subjects. 
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Figure 3. Mitochondrial carbonylation. Grouped old (O) + old sarcopenic 
(OS) versus young (y) protein carbonylation data from the mitochondrial frac-
tions. Values are presented as means ± SeM; *Indicates p ≤ .05. 
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suggested to decrease with age (34), our results indicate 
that human aging in either the absence or presence of des-
ignated sarcopenia is not associated with modulation of 
HSP abundance, per se (at least for those we measured), in 
leg skeletal muscle.
In conclusion, we have shown that protein carbonyl 
adducts in skeletal muscle were not altered in older sub-
jects with sarcopenia (stage-I) versus those without. From 
this result, we conclude that protein carbonylation may 
not be directly responsible for the occurrence of sarco-
penia. Nevertheless, as protein oxidation is an indirect 
measure of oxidative stress, we cannot discern links between 
ROS/reactive nitrogen species (RNS) and protein carbon-
ylation in our subjects.  Interestingly, increased abundance 
of mitochondrial protein carbonyls in older versus younger 
adults (older individuals were generally weaker and with 
reduced lean mass [see Table  1]), and the association 
between increased mitochondrial protein carbonylation and 
decreased muscle strength, points to mitochondrial oxidation 
status representing a previously undefined generic “marker” 
of low muscle strength. Finally, although there was a ten-
dency toward an association between mitochondrial protein 
Figure 5.  Immunochemical detection of heat shock protein (HSP) expression in muscle of young, old, and old sarcopenic subjects at rest. (A) HSPs analyzed in 
sarcoplasmic protein fraction and (B) HSPs from myofibrillar protein fraction. Data are measured in arbitrary units, measured as the ratio between the optical density 
(OD) of marker protein and the OD of pan actin. Representative samples are shown. Values are presented as means ± SeM. 
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carbonylation and muscle mass (p = .13; two-tailed: p = .06; 
one-tailed: r2 = −.08), further research with larger cohorts 
would be needed to confirm or refute such a relationship.
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